Tag: myelodysplastic syndrome December 16, 2024 $10.8 million grant supports cutting-edge leukemia researchNIH renews prestigious program for blood cancer research at WashU Medicine.News Release December 5, 2024 New drug tested to reduce side effect of ‘half-matched’ stem cell transplantsClinical trial indicates safety, fewer cases of life-threatening graft-versus-host disease than expected.News Release November 22, 2024 World leaders in ending blood cancerThe Siteman Blood Cancer Center, which brings together the multidisciplinary expertise of WashU Medicine physicians, has long been at the forefront of transforming care. .Outlook Magazine March 10, 2021 Promising role for whole genome sequencing in guiding blood cancer treatmentSequencing results returned in a few days; costs similar to conventional testing.News Release January 17, 2020 Walter named Edward P. Evans Endowed ProfessorOncologist honored for research, patient care in myelodysplastic syndromes.News Release September 11, 2019 $5 million grant endows research to advance blood disorder therapiesEdward P. Evans Foundation funds new center focused on myelodysplastic syndromes.News Release February 20, 2019 Clinical Research Forum recognizes top studiesOncologists show way to ID patients at high risk of cancer recurrence. September 12, 2018 Genetic testing helps predict disease recurrence in myelodysplastic syndromeLikelihood of recurrence high if mutations detectable after stem cell transplant.News Release Posts navigation
